This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Uwe Muenster: Innovator in Antiandrogenic Treatments
Introduction
Uwe Muenster is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for androgenic conditions. His innovative work has led to the creation of a patent that addresses important health issues.
Latest Patents
Uwe Muenster holds a patent for "Preparations for topical administration of substances having antiandrogenic activity." This preparation includes at least one form of lipid nanoparticles or a nanoemulsion containing compounds suitable for treating androgenic alopecia and hirsutism. The formulation is designed to prevent unwanted hair growth and is also applicable in treating seborrhea and acne. This patent highlights his commitment to advancing medical treatments through innovative formulations.
Career Highlights
Muenster is associated with Aventis Pharma Deutschland GmbH, where he has contributed to various research and development projects. His work has focused on creating effective solutions for dermatological conditions, showcasing his expertise in pharmaceutical sciences. His dedication to innovation has positioned him as a key figure in his field.
Collaborations
Uwe Muenster has collaborated with notable colleagues, including Karl Theodor Kraemer and Karl-Heinz Nietsch. These partnerships have fostered a collaborative environment that enhances the development of new treatments and technologies.
Conclusion
Uwe Muenster's contributions to the field of antiandrogenic treatments exemplify the impact of innovative thinking in pharmaceuticals. His patent and collaborative efforts reflect a commitment to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
